A Fourth Vaccine on the Horizon?

In a new analysis of its phase three trial in the United States, AstaZeneca has determined their COVID-19 vaccine to be 76% effective. This new data shows a three percent change from their initial report earlier this week stating their efficacy rate to be 79% effective against the coronavirus disease. AstraZeneca’s original filing came under public scrutiny from health officials in the United States because their data did not include more recent infections.

Read More

March Madness 2021 Boom or Bust for Crude

Crude has been the underdog since Covid-19 broke onto the scene in early March of 2020. We have seen historic contango, negative trading, inventories at the verge of 100% capacity. However, we have also seen refineries curtailing production and shutting down, crude breaking technical level after level, OPEC + committing to decreased outputs, a Texas winter weather creating supply concerns, and a slow steady recovery of crude as inventories are drawn down and production resumes. Crude has built a full head of steam and looks to be an unstoppable force and a surefire pick to rise to glory yet again for 2021. March Madness is known for its volatile emotional up and downs and surprise sleeper teams with unimaginable upsets. Will 2021 and a third European lockdown amid vaccine safety concerns be the sleeper to upset the rise of Crude?!

Read More